文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

评估二价疫苗作为新冠病毒病的第二剂加强针

An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19.

作者信息

Gupta Sneh Lata, Jaiswal Rishi K

机构信息

Department of Pediatrics, Division of Infectious Disease, School of Medicine, Emory University, Atlanta, GA 30322, USA.

Cardinal Bernardin Cancer Center, Department of Cancer Biology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.

出版信息

Vaccines (Basel). 2022 Dec 29;11(1):79. doi: 10.3390/vaccines11010079.

DOI:10.3390/vaccines11010079
PMID:36679924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9863048/
Abstract

In the USA, two monovalent COVID-19 mRNA vaccines are primarily used for vaccination [...].

摘要

在美国，两种单价新冠病毒mRNA疫苗主要用于疫苗接种[……]

相似文献

[1]
An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19.

Vaccines (Basel). 2022-12-29

[2]
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.

Lancet Infect Dis. 2023-9

[3]
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.

Lancet Infect Dis. 2023-12

[4]
Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study.

Lancet Infect Dis. 2023-10

[5]
Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022.

Euro Surveill. 2023-11

[6]
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.

MMWR Morb Mortal Wkly Rep. 2022-12-30

[7]
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.

MMWR Morb Mortal Wkly Rep. 2023-3-17

[8]
Real-world evidence on the efficacy of bivalent booster doses of SARS-CoV-2 vaccine in respect of monovalent boosters or primary cycle of vaccination: a narrative review.

Epidemiol Prev. 2023

[9]
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.

MMWR Morb Mortal Wkly Rep. 2022-11-11

[10]
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.

MMWR Morb Mortal Wkly Rep. 2023-1-13

引用本文的文献

[1]
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.

Vaccines (Basel). 2024-12-28

[2]
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination.

Vaccines (Basel). 2023-12-28

[3]
Role of Immunoglobulin A in COVID-19 and Influenza Infections.

Vaccines (Basel). 2023-10-27

[4]
Children's SARS-CoV-2 Infection and Their Vaccination.

Vaccines (Basel). 2023-2-12

本文引用的文献

[1]
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.

JAMA Netw Open. 2023-3-1

[2]
Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.

N Engl J Med. 2023-3-2

[3]
Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.

N Engl J Med. 2023-2-9

[4]
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.

N Engl J Med. 2023-2-9

[5]
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.

N Engl J Med. 2023-1-12

[6]
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.

MMWR Morb Mortal Wkly Rep. 2022-11-11

[7]
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.

Nat Med. 2023-1

[8]
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5.

Cell Discov. 2022-10-11

[9]
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.

Nat Med. 2022-11

[10]
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.

N Engl J Med. 2022-10-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索